Under construction – not a live service
Sign in
Not yet recruitingNo phase

Rehabilitation Assessment of Motor Function In Cerebral Palsy Using Explainable AI

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 4 and 18 years old?

Source: NCT07629024, who can take part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Riphah International University
Trial code
NCT07629024
Record updated
10 August 2026
Original description
The goal of this observational study is to develop and validate an AI-based prediction model for functional mobility and gait outcomes in children with cerebral palsy using low-cost clinical and gait data collected in rehabilitation settings in Pakistan.Read full original descriptionShow less

Rehabilitation Assessment of Motor Function in Ambulatory Children With Cerebral Palsy Using Explainable Machine Learning

The goal of this observational study is to develop and validate an AI-based prediction model for functional mobility and gait outcomes in children with cerebral palsy using low-cost clinical and gait data collected in rehabilitation settings in Pakistan.

Inclusion: Age 4 to18 years; Diagnosed any motor type of cerebral palsy (spastic, dyskinetic, ataxic, mixed),); GMFCS levels I -III (able to walk with or without an assistive device); All participants must be able to ambulate at least 10 meters with or without an assistive device; Capable of following simple verbal instructions; Parental informed consent and child assent.

Exclusion: Uncontrolled seizures affecting gait; Recent orthopedic or neurosurgical interventions (<6 months); Non-ambulatory (GMFCS IV-V) or cognitive impairments preventing cooperation.

ClinicalTrials.gov NCT07629024